These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11188729)

  • 21. [Genetic aspects of chronic cardiac failure].
    Tereshchenko SN; Dzhaiani NA; Moiseev VS
    Ter Arkh; 2000; 72(4):75-7. PubMed ID: 10833807
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cathecholamine in heart failure (author's transl)].
    Yazaki Y; Ikeda M
    Kokyu To Junkan; 1975 May; 23(5):397-404. PubMed ID: 169560
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myocardial metabolism in failing and hypertrophied hearts].
    Yazaki Y
    Kokyu To Junkan; 1987 Mar; 35(3):243-50. PubMed ID: 2954195
    [No Abstract]   [Full Text] [Related]  

  • 24. What are the consequences of phosphorylation and hyperphosphorylation of ryanodine receptors in normal and failing heart?
    Bridge JH; Savio-Galimberti E
    Circ Res; 2008 May; 102(9):995-7. PubMed ID: 18467636
    [No Abstract]   [Full Text] [Related]  

  • 25. Biology of cardiac overload. A review.
    Dambrin G; Bonnet D; Swynghedauw B
    J Heart Valve Dis; 1994 Nov; 3(6):627-33. PubMed ID: 8000605
    [No Abstract]   [Full Text] [Related]  

  • 26. Manipulating cardiac contractility in heart failure: data from mice and men.
    Dorn GW; Molkentin JD
    Circulation; 2004 Jan; 109(2):150-8. PubMed ID: 14734503
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biochemical and molecular aspects of myocardial contraction and the pathophysiologic and hemodynamic bases of modern therapy of cardiac insufficiency].
    Trifunovic S; Sćekić V; Florijan V; Florijan V; Cikos J; Vitić B
    Med Pregl; 1981; 34(9-10):393-400. PubMed ID: 7341934
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative and qualitative disorders of energy transformation in the myocardial contractile protein system--a pivotal process in the development of heart failure].
    Karsanov NV; Magaldadze VA; Macharashvili TN; Sukoian GV; Tatulashvili DR
    Vestn Akad Med Nauk SSSR; 1988; (12):60-8. PubMed ID: 3239219
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic remodelling of the failing heart: beneficial or detrimental?
    van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
    Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholamban: a key determinant of cardiac function and dysfunction.
    Rodriguez P; Kranias EG
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiology and pathobiochemistry of heart failure: the myocardium].
    Schultheiss HP
    Verh Dtsch Ges Inn Med; 1991; 97():164-74. PubMed ID: 1808880
    [No Abstract]   [Full Text] [Related]  

  • 32. Heart disease. How to subdue a swelling heart.
    Marx J
    Science; 2003 Jun; 300(5625):1492-6. PubMed ID: 12791957
    [No Abstract]   [Full Text] [Related]  

  • 33. [The lipid content of the myocardium as a function of cardiac work and of experimental cardiac insufficiency (rat heart-lung preparation)].
    Minelli R; Panagia V; Sciorelli G
    Arch Sci Biol (Bologna); 1968; 52(3):254-62. PubMed ID: 5702571
    [No Abstract]   [Full Text] [Related]  

  • 34. No low-fat diet for the failing heart?
    Taegtmeyer H; Ballal K
    Circulation; 2006 Nov; 114(20):2092-3. PubMed ID: 17101867
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative study of myocardial high energy phosphate substrate content in slow and fast growing chicken and in chickens with heart failure and ascites.
    Olkowski AA; Nain S; Wojnarowicz C; Laarveld B; Alcorn J; Ling BB
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Sep; 148(1):230-8. PubMed ID: 17524693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction.
    Most P; Seifert H; Gao E; Funakoshi H; Völkers M; Heierhorst J; Remppis A; Pleger ST; DeGeorge BR; Eckhart AD; Feldman AM; Koch WJ
    Circulation; 2006 Sep; 114(12):1258-68. PubMed ID: 16952982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathology of cardiac insufficiency].
    Stolte M
    Fortschr Med; 1979 May; 97(17):799-805. PubMed ID: 437642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired energetics in heart failure - a new therapeutic target.
    Ormerod JO; Ashrafian H; Frenneaux MP
    Pharmacol Ther; 2008 Sep; 119(3):264-74. PubMed ID: 18602947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Another calcium paradox in heart failure.
    Kass RS; Lindegger N; Hagen B; Lederer WJ
    J Mol Cell Cardiol; 2008 Jul; 45(1):28-31. PubMed ID: 18504047
    [No Abstract]   [Full Text] [Related]  

  • 40. Heart spotting.
    el Azzouzi H; De Windt LJ
    Basic Res Cardiol; 2008 May; 103(3):228-31. PubMed ID: 18274799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.